Abstract

<h3>Introduction</h3> Malignant tumor cells have an increased proliferation rate and increased demand for amino acids. This physiochemical phenomenon can be visualized by PET. The potential of L-l-[C-11]tyrosine (TYR) to visualize STS or melanoma and quantify the protein synthesis rate (PSR) was investigated <h3>Methods</h3> 12 patients (pts) with a tumor were studied, mean age 50 (range 24–74) yrs received 296±92 MBq TYR IV. All pts were studied in a dynamic mode, images were corrected for attenuation with a transmission scan. Arterial blood samples were taken for measurement of the tyrosine input function, and the assessment of tyrosine metabolites ([C-11]CO<sub>2</sub>, [C-11]) proteins. Region of interest was placed over the tumor and PSR of the tumor was calculated with the use of computer analysis (Patlak). Histology was obtained after PET. <h3>Results</h3> All malignant and benign lesions were correctly identified with TYR-PET. The malignant lesions depicted as a hot spot, the benign lesions as a cold spot. The mean PSR's (nmol/ml/min) and Tumor-to-Muscle ratio (TM ratio) are statistically significant between malignant and benign lesions (P=0.03). <h3>Condusion</h3> TYR is applicable for the visualization of STS and melanoma, PSR may allow future use in the evaluation of chemotherapy or radiotherapy.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.